The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.

09 February 2019 Written by CN1699 Services Article viewed 7 times (4 times in the last week)

Each year around 9,800 people in the UK are diagnosed with pancreatic cancer. Scar tissue is a particular problem in the disease, where it forms the largest proportion of tumour volume out of any type of cancer.

The intense scar tissue forms a protective wall around the cancer, hampering treatments including chemotherapy, immunotherapy or radiotherapy. This contributes to it being a particularly aggressive disease, with the lowest survival rate of all cancers - fewer than five per cent of patients survive for five years or more.

For more information, visit: Eurekalert

Queen Mary University of London is a public research university in London, England.

Read more related topics:

Cancer | Cancer Treatment | Pancreatic Cancer |

Source: Eurekalert

Grace T

Managing Editor - CN1699 Services